Mutual Information Analysis Reveals Coevolving Residues in Tat That Compensate for Two Distinct Functions in HIV-1 Gene Expression*

Background: It is not well understood how HIV-1 Tat performs complex functions despite its considerable sequence diversity. Results: Individually nonconserved but functionally coevolving sites in Tat were identified. Conclusion: In contrast to most coevolving sites, these sites are critical for two distinct functions regulating viral gene expression. Significance: Balancing the two mechanisms is a strategy to maintain Tat function and may impact viral latency. Viral genomes are continually subjected to mutations, and functionally deleterious ones can be rescued by reversion or additional mutations that restore fitness. The error prone nature of HIV-1 replication has resulted in highly diverse viral sequences, and it is not clear how viral proteins such as Tat, which plays a critical role in viral gene expression and replication, retain their complex functions. Although several important amino acid positions in Tat are conserved, we hypothesized that it may also harbor functionally important residues that may not be individually conserved yet appear as correlated pairs, whose analysis could yield new mechanistic insights into Tat function and evolution. To identify such sites, we combined mutual information analysis and experimentation to identify coevolving positions and found that residues 35 and 39 are strongly correlated. Mutation of either residue of this pair into amino acids that appear in numerous viral isolates yields a defective virus; however, simultaneous introduction of both mutations into the heterologous Tat sequence restores gene expression close to wild-type Tat. Furthermore, in contrast to most coevolving protein residues that contribute to the same function, structural modeling and biochemical studies showed that these two residues contribute to two mechanistically distinct steps in gene expression: binding P-TEFb and promoting P-TEFb phosphorylation of the C-terminal domain in RNAPII. Moreover, Tat variants that mimic HIV-1 subtypes B or C at sites 35 and 39 have evolved orthogonal strengths of P-TEFb binding versus RNAPII phosphorylation, suggesting that subtypes have evolved alternate transcriptional strategies to achieve similar gene expression levels.

[1]  D. Bentley,et al.  Dynamic association of capping enzymes with transcribing RNA polymerase II. , 2000, Genes & development.

[2]  D. Richman,et al.  Update of the drug resistance mutations in HIV-1: December 2010. , 2010, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[3]  P. Luciw,et al.  Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product , 1987, Nature.

[4]  F. Kashanchi,et al.  Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. , 2000, Virology.

[5]  Simon A. A. Travers,et al.  A Novel Method for Detecting Intramolecular Coevolution: Adding a Further Dimension to Selective Constraints Analyses , 2006, Genetics.

[6]  K. Jeang,et al.  Modulation of Sp1 Phosphorylation by Human Immunodeficiency Virus Type 1 Tat , 1998, Journal of Virology.

[7]  L. C. Martin,et al.  Using information theory to search for co-evolving residues in proteins , 2005, Bioinform..

[8]  C. Sander,et al.  Correlated Mutations and Residue Contacts , 1994 .

[9]  Qiang Zhou,et al.  The Yin and Yang of P-TEFb Regulation: Implications for Human Immunodeficiency Virus Gene Expression and Global Control of Cell Growth and Differentiation , 2006, Microbiology and Molecular Biology Reviews.

[10]  Gregory B. Gloor,et al.  Mutual information without the influence of phylogeny or entropy dramatically improves residue contact prediction , 2008, Bioinform..

[11]  J. Belasco,et al.  A Structural Model for the HIV-1 Rev–RRE Complex Deduced from Altered-Specificity Rev Variants Isolated by a Rapid Genetic Strategy , 1996, Cell.

[12]  C. Sander,et al.  Correlated mutations and residue contacts in proteins , 1994, Proteins.

[13]  M. Negroni,et al.  Mechanisms of retroviral recombination. , 2001, Annual review of genetics.

[14]  Manel Camps,et al.  Genetic Constraints on Protein Evolution , 2007, Critical reviews in biochemistry and molecular biology.

[15]  R. Ranganathan,et al.  Evolutionarily conserved pathways of energetic connectivity in protein families. , 1999, Science.

[16]  Sergei Nekhai,et al.  Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription , 2006, Retrovirology.

[17]  E. Verdin,et al.  The Cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription. , 2010, Cell host & microbe.

[18]  Alan D. Frankel,et al.  RNA-mediated displacement of an inhibitory snRNP complex activates transcription elongation , 2010, Nature Structural &Molecular Biology.

[19]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[20]  S. Goff,et al.  Analysis of mutations and suppressors affecting interactions between the subunits of the HIV type 1 reverse transcriptase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Wainberg,et al.  Regulation of Human Immunodeficiency Virus Type 1 Gene Expression by Clade-Specific Tat Proteins , 2005, Journal of Virology.

[22]  H. Phatnani,et al.  Phosphorylation and functions of the RNA polymerase II CTD. , 2006, Genes & development.

[23]  F. Kashanchi,et al.  Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription , 2006, Retrovirology.

[24]  B. Margolis,et al.  Autophosphorylation mutants of the EGF-receptor signal through auxiliary mechanisms involving SH2 domain proteins. , 1994, Oncogene.

[25]  T. Tahirov,et al.  Crystal structure of HIV-1 Tat complexed with human P-TEFb , 2010, Nature.

[26]  Junmin Peng,et al.  Tat Modifies the Activity of CDK9 To Phosphorylate Serine 5 of the RNA Polymerase II Carboxyl-Terminal Domain during Human Immunodeficiency Virus Type 1 Transcription , 2000, Molecular and Cellular Biology.

[27]  R. Young,et al.  Association of Cdk-activating kinase subunits with transcription factor TFIIH , 1995, Nature.

[28]  B. Berkhout,et al.  A Second-Site Mutation That Restores Replication of a Tat-Defective Human Immunodeficiency Virus , 1999, Journal of Virology.

[29]  Eric Verdin,et al.  The SWI/SNF Chromatin-remodeling Complex Is a Cofactor for Tat Transactivation of the HIV Promoter* , 2006, Journal of Biological Chemistry.

[30]  A. Horovitz,et al.  Mapping pathways of allosteric communication in GroEL by analysis of correlated mutations , 2002, Proteins.

[31]  Peter B Gilbert,et al.  Covariability of selected amino acid positions for HIV type 1 subtypes C and B. , 2005, AIDS research and human retroviruses.

[32]  J. Luban,et al.  Rescue of Multiple Viral Functions by a Second-Site Suppressor of a Human Immunodeficiency Virus Type 1 Nucleocapsid Mutation , 2000, Journal of Virology.

[33]  A. Lapedes,et al.  Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: an information theoretic analysis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. Ikuta,et al.  Human Immunodeficiency Virus Type 1 Subtype C Exhibits Higher Transactivation Activity of Tat than Subtypes B and E , 2002, Microbiology and immunology.

[35]  M. Giacca,et al.  HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Trono,et al.  A Third-Generation Lentivirus Vector with a Conditional Packaging System , 1998, Journal of Virology.

[37]  A. Burlingame,et al.  HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. , 2010, Molecular cell.

[38]  T. Hwa,et al.  Identification of direct residue contacts in protein–protein interaction by message passing , 2009, Proceedings of the National Academy of Sciences.

[39]  Priya S. Shah,et al.  Control of Stochastic Gene Expression by Host Factors at the HIV Promoter , 2009, PLoS pathogens.

[40]  K. Jones,et al.  SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation. , 2009, Molecular cell.

[41]  Michael T. Laub,et al.  Rewiring the Specificity of Two-Component Signal Transduction Systems , 2008, Cell.

[42]  Jared E. Toettcher,et al.  Stochastic Gene Expression in a Lentiviral Positive-Feedback Loop: HIV-1 Tat Fluctuations Drive Phenotypic Diversity , 2005, Cell.

[43]  R. Berro,et al.  Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR , 2008, Retrovirology.

[44]  A. Burny,et al.  HIV‐1 Tat transcriptional activity is regulated by acetylation , 1999, The EMBO journal.

[45]  S. Richard,et al.  Arginine Methylation of the Human Immunodeficiency Virus Type 1 Tat Protein by PRMT6 Negatively Affects Tat Interactions with both Cyclin T1 and the Tat Transactivation Region , 2007, Journal of Virology.

[46]  K. Crandall,et al.  The causes and consequences of HIV evolution , 2004, Nature Reviews Genetics.

[47]  D. Richman,et al.  2022 update of the drug resistance mutations in HIV-1. , 2022, Topics in antiviral medicine.

[48]  Deenan Pillay,et al.  Update of the Drug Resistance Mutations in HIV-1: December 2008 , 2008 .

[49]  Mauricio G Mateu,et al.  Electrostatic repulsion, compensatory mutations, and long-range non-additive effects at the dimerization interface of the HIV capsid protein. , 2005, Journal of molecular biology.

[50]  Adam P. Arkin,et al.  HIV Promoter Integration Site Primarily Modulates Transcriptional Burst Size Rather Than Frequency , 2010, PLoS Comput. Biol..

[51]  D. Harrich,et al.  Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription , 2005, Virology Journal.

[52]  D. Gilmour,et al.  Negative Elongation Factor NELF Represses Human Immunodeficiency Virus Transcription by Pausing the RNA Polymerase II Complex* , 2007, Journal of Biological Chemistry.

[53]  N. Sonenberg,et al.  A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. , 1990, Disease markers.